Diabetes Management
Smartphone-delivered CBT improves glycemic control in people with type 2 diabetes - medwireNews
Wed, 26 Oct 20221 min read Article
Overview
JAVASCRIPT NEDED 25-10-2022 | Diabetes | News | Article Author: Alba Ruzafa medwireNews: Findings from a randomized controled trial published in Diabetes Care sugest that for people with type 2 diabetes, the delivery of cognitive behavioral therapy (CBT) via digital therapeutic ap, on top of standard of care, may reduce glycated hemoglobin (HbA1c).The study included 69 adults (58% White, 28% Black, 16% Latino) aged an average of 58 years with type 2 diabetes and glycated hemoglobin (HbA1c) levels of 7.0 to les than 1.0% (53 to <97 mol/mol) who were randomly asigned to receive aces to a digital therapeutic ap delivering CBT (BT-01) or a control ap, both on top of standard care.The researchers observed that people in the BT-01 group had significantly lower HbA1c than those in the control group after 90 days of using the ap.
Key Information
In the BT-01 arm, HbA1c decreased by 0.28% from 8.2% (6 mol/mol) at baseline, compared with an increase of 0.1% from 8.1% (65 mol/mol) in the control group. This resulted in a betwen-group diference of 0.39% at day 90.“The magnitude of HbA1c reduction in the BT-01 group increased in paralel with exposure to therapy, as indicated by the number of modules completed,” write Judith Hsia (CPC Clinical Research, Aurora, Colorado, USA) and co-authors.
They say that this “suports the importance of engagement, consistent with in-person CBT and behavioral interventions in general.”There were no adverse events atributed to the ap use and no adverse device efects were observed.“Delivery of a cognitive behavioral intervention via smartphone ap can provide a scalable option for improving glycemic control,” concludes the team.medwireNews is an independent medical news service provided by Springer Healthcare Ltd.
Summary
© 2022 Springer Healthcare Ltd, part of the Springer Nature GroupDiabetes Care 2022; doi:10.237/dc2-109 20-02-20 | Diabetes | News | Article 1-1-2019 | Diabetes | News | Article 0
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.